Diabetes, Autoimmune: Clinical Trials

13 trials for Diabetes, Autoimmune, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

6 completed, 2 recruiting, 1 enrolling by invitation, 1 not yet recruiting. 4 Not applicable, 4 Phase 2, 2 Phase 1, 1 Phase 4.

By phase and status

PhaseTrialsStatus
Not applicable4Completed 2, Recruiting 2
Phase 24Completed 2, Terminated 1, Withdrawn 1
Phase 12Completed 1, Withdrawn 1
Phase 41Completed 1

Follow Diabetes, Autoimmune: new trials by email Literature Review of Diabetes, Autoimmune trials Research Report on Diabetes, Autoimmune

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Primary Care Pragmatic, Real World Experience for Automated Insulin Delivery
Bionic Pancreas, Routine Care - Type 1 Diabetes (T1D), Type 2 Diabetes
Not applicableRecruitingUniversity of Colorado, Denver2402026-01-162026-06-11
Mapping Diabetes in Quebec: Validating Medico-administrative Algorithms for Type 1 Diabetes, Type 2 Diabetes and LADA
no intervention - Diabetes Mellitus, Type 1, Diabete Type 2
Not yet recruitingUniversite du Quebec en Outaouais172712025-01-012025-01-01
Behavioral Approaches to Reduce Diabetes Distress in Adults With Type 1 Diabetes: A Pragmatic SMART
ReCharge, TakeCharge - Diabetes type1, Diabetes Mellitus, Type 1
Not applicableRecruitingUniversity of North Carolina, Chapel Hill2002024-10-012025-10-29
Pilot of Pragmatic Delivery of Behavioral Approaches to Reduce Diabetes Distress in Adults With Type 1 Diabetes
ReCharge, TakeCharge - Diabetes type1, Diabetes Mellitus, Type 1
Not applicableCompletedUniversity of North Carolina, Chapel Hill122024-07-222024-12-05
Type 1 Diabetes Autonomic and Vascular Function
Type 1 Diabetes (Juvenile Onset), Type 1 Diabetes
Enrolling by invitationUniversity of Texas at Austin722023-08-072025-09-12
Low-dose IL-2 in Established T1D - The "PROREG" Study
ILT-101 (Aldesleukin; IL-2), Treatment-Placebo Arm, Placebo Arm - Diabetes Mellitus, Type 1, Diabetes
Phase 1 / Phase 2WithdrawnJay S. Skyler2023-06-012024-05-22
Feasibility of Closed-loop Automated Insulin Delivery System by Primary Care & Endocrinology, in Person & Via Telehealth
Bionic Pancreas, Usual Care - Diabetes Mellitus, Type 1, Type 1 Diabetes
Not applicableCompletedUniversity of Colorado, Denver542022-03-312024-10-21
Control of Renal Oxygen Consumption, Mitochondrial Dysfunction, and Insulin Resistance
Aminohippurate Sodium Inj 20%, Iohexol Inj 300 milligrams/milliliter (mg/ml), PET/CT Scan - Diabetic Kidney Disease, Type 1 Diabetes
CompletedUniversity of Colorado, Denver582020-01-012023-02-09
Characteristics of Young-onset Diabetes in Sub-Saharan Africa (YODA) Study
No intervention needed - Type 1 Diabetes, Diabetes, Autoimmune
UnknownYaounde Central Hospital12002019-09-012021-08-19
Evaluation of Coffee Therapy for Improvement of Renal Oxygenation
StarbucksĀ® Cold brew - 325ml bottle - Type1diabetes, Type1 Diabetes Mellitus
Phase 2CompletedUniversity of Colorado, Denver102019-07-012022-02-15
Pilot Study of OMEGA-3 and Vitamin D in High-Dose in Type I Diabetic Patients
Cholecalciferol, Omega 3 fatty acid - Diabetes Mellitus, Type 1, Hypoglycemia
Phase 1 / Phase 2CompletedRodolfo Alejandro272018-07-232025-09-17
Safety, Tolerability, Immunological and Clinical Efficacy of Multiple Subcutaneous Doses of DiaPep277 in Latent Autoimmune Diabetes in Adults (LADA)
DiaPep277 - Diabetes, Autoimmune
Phase 2TerminatedDeveloGen Israel, Ltd.1002002-10-012009-03-19
Early Insulin Treatment in Patients With Latent Autoimmune Diabetes
Insulin - Diabetes, Autoimmune, Diabetes Mellitus, Adult-Onset
Phase 4CompletedLund University Hospital421995-02-012010-04-23

Narrower conditions

Diabetes Mellitus, Type 1 (13)  ·  Diabetes Mellitus (8)  ·  Diabetes Mellitus, Type 2 (3)  ·  Diabetes Complications (2)  ·  Diabetic Nephropathies (2)  ·  Insulin Resistance (2)  ·  Hyperemia (1)  ·  Hypoglycemia (1)  ·  Latent Autoimmune Diabetes in Adults (1)

Broader conditions

Autoimmune Diseases (13)  ·  Endocrine System Diseases (13)  ·  Glucose Metabolism Disorders (13)  ·  Immune System Diseases (13)  ·  Metabolic Diseases (13)  ·  Nutritional and Metabolic Diseases (13)  ·  Diabetes Mellitus (5)  ·  Female Urogenital Diseases (2)  ·  Female Urogenital Diseases and Pregnancy Complications (2)  ·  Hyperinsulinism (2)  ·  Kidney Diseases (2)  ·  Male Urogenital Diseases (2)  ·  Urogenital Diseases (2)  ·  Urologic Diseases (2)  ·  Cardiovascular Diseases (1)

Interventions

Cholecalciferol (1)  ·  Docosahexaenoic Acids (1)  ·  Fatty Acids, Omega-3 (1)  ·  Insulin (1)  ·  Interleukin-2 (1)  ·  Iohexol (1)  ·  Vitamin D (1)  ·  aldesleukin (1)  ·  p-Aminohippuric Acid (1)

Sponsors

University of Colorado, Denver (4)  ·  University of North Carolina, Chapel Hill (2)  ·  DeveloGen Israel, Ltd. (1)  ·  Jay S. Skyler (1)  ·  Lund University Hospital (1)  ·  Rodolfo Alejandro (1)  ·  Universite du Quebec en Outaouais (1)  ·  University of Texas at Austin (1)  ·  Yaounde Central Hospital (1)

Countries

United States (10)  ·  Cameroon (1)  ·  Canada (1)  ·  South Africa (1)  ·  Tanzania (1)  ·  Uganda (1)

Top investigators

Anna Kahkoska, MD, PhD (2)  ·  Alberto Pugliese, M.D. (1)  ·  Camillo Ricordi, M.D. (1)  ·  Dana Elias, PhD (1)  ·  David A Baidal, M.D. (1)  ·  Eugene Sobgnwi, MD, PhD (1)  ·  Jay S Skyler, M.D. (1)  ·  Jerry P Palmer, MD (1)  ·  Petter Bjornstad, MD (1)  ·  Sean M Oser, MD, MPH (1)  ·  Sean Oser, MD, MPH, CDCES (1)  ·  Tamara K Oser, MD (1)

Results publications

PMID 24408401, PMID 38621633, PMID 39436695, PMID 42674789